NASDAQ:OMED - Oncomed Pharmaceuticals Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $0.8005 +0.01 (+1.27 %) (As of 12/16/2018 05:21 AM ET)Previous Close$0.8005Today's Range$0.7301 - $0.866052-Week Range$0.73 - $4.20Volume1.70 million shsAverage Volume414,769 shsMarket Capitalization$30.52 millionP/E Ratio-0.77Dividend YieldN/ABeta1.95 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Oncomed Pharmaceuticals (NASDAQ:OMED) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.3 Wall Street analysts have issued ratings and price targets for Oncomed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $3.1667, suggesting that the stock has a possible upside of 295.59%. The high price target for OMED is $6.00 and the low price target for OMED is $1.50. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.002.002.252.20Ratings Breakdown: 0 Sell Rating(s)3 Hold Rating(s)0 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)0 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)1 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)1 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $3.1667$4.00$4.50$4.60Price Target Upside: 295.59% upside65.98% upside46.10% upside49.35% upsideOncomed Pharmaceuticals (NASDAQ:OMED) Consensus Price Target History Oncomed Pharmaceuticals (NASDAQ:OMED) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails12/6/2018Wells Fargo & CoReiterated RatingOutperform ➝ Market Perform$8.00 ➝ $1.50High9/21/2018HC WainwrightLower Price TargetNeutral$3.00 ➝ $2.00High1/4/2018Cantor FitzgeraldSet Price TargetHold$6.00High10/6/2017SunTrust BanksReiterated RatingHold$4.00N/A9/28/2017Jefferies Financial GroupReiterated RatingBuy$5.00Low7/10/2017Piper Jaffray CompaniesSet Price TargetHold$5.00Medium4/17/2017JMP SecuritiesDowngradeOutperform ➝ Market PerformLow4/11/2017Leerink SwannBoost Price TargetMarket Perform$6.00 ➝ $10.00High4/11/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$6.00High(Data available from 12/16/2016 forward) This page was last updated on 12/16/2018 by MarketBeat.com StaffFeatured Article: What is a Derivative?